📢 Product Launch Announcement: Ondoforce MD 8

We are proud to introduce Ondoforce MD 8, a clinically advanced, orally disintegrating formulation of Ondansetron 8 mg, developed to provide rapid and effective control of nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative recovery.

With its fast-dissolving technology and powerful anti-emetic action, Ondoforce MD 8 delivers trusted, patient-centric care that enhances treatment outcomes and improves patient experience.

🔹 About Ondoforce MD 8

• Active Ingredient: Ondansetron 8 mg (Orally Disintegrating Tablet)
• Therapeutic Class: Anti-Emetic / 5-HT₃ Receptor Antagonist
• Primary Indications:
  • Prevention and treatment of:
    • Chemotherapy-induced nausea and vomiting (CINV)
    • Radiotherapy-induced nausea and vomiting (RINV)
    • Postoperative nausea and vomiting (PONV))
• Mechanism of Action:
  Ondansetron acts by selectively inhibiting serotonin (5-HT₃) receptors both centrally in the chemoreceptor trigger zone and peripherally in the gastrointestinal tract, thereby preventing the activation of the vomiting reflex.

🔹 Key Features & Benefits

Orally Disintegrating Technology

• Dissolves quickly on the tongue without the need for water, providing ease of administration for patients experiencing nausea.

✅ Higher Strength for Robust Anti-Emetic Coverage

• 8 mg dosage offers enhanced efficacy, particularly for moderate to highly emetogenic chemotherapy regimens.

✅ Rapid Onset of Action

• Fast therapeutic effect to control nausea and prevent vomiting at critical treatment points.

✅ Convenient, Patient-Friendly Design

• Improves patient compliance, especially among pediatric, geriatric, and post-surgical populations.

✅ Excellent Tolerability and Safety Profile

• Well-documented safety record across a wide range of clinical settings.

🏥 Hospitals, Oncology Centers, Surgical Units

• Providing essential support across cancer treatment, surgery, and critical care departments.

👨‍⚕️ Oncologists, Anesthesiologists, General Surgeons, Physicians

• Enabling medical professionals to offer reliable, fast-acting anti-emetic therapy.

🧑‍🤝‍🧑 Patients Undergoing Chemotherapy, Radiotherapy, or Surgery

• Offering critical comfort and protection during vulnerable stages of treatment.

🔹 Our Commitment

At Green Apple Pharmaceuticals Private Limited, we are dedicated to pioneering therapies that are as reliable as they are innovative. Ondoforce MD 8 stands as a testament to our mission: Delivering faster relief, stronger protection, and better patient care.

Ondoforce MD 8 — Redefining Comfort in Critical Moments.

📦 Now Available

For detailed prescribing information, clinical usage guidelines, or support materials, please contact our medical team or visit Ondoforce MD 8.